News
A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...
What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...
1d
Study Finds on MSNHow Magnetic Brain Stimulation May Reactivate Memory Circuits In Alzheimer’sIn a nutshell Scientists used magnetic brain stimulation to restore damaged connections in mice with Alzheimer’s-like ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
Life Molecular Imaging, Ltd. (LMI) announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Neuraceq® (florbetaben F18 injection), expanding its indication for ...
Researchers have developed a blood test that detects Alzheimer's biomarkers at single-molecule levels, enabling earlier, ...
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins ...
New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...
According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results